These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 11043971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
    Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF.
    Ann Neurol; 2015 Nov; 78(5):710-21. PubMed ID: 26239536
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 5. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S, Neema M, Healy BC, Weiner HL, Bakshi R.
    J Neurol Sci; 2014 Nov 15; 346(1-2):250-4. PubMed ID: 25220114
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of tissue injury in MS lesions.
    Trapp BD, Bö L, Mörk S, Chang A.
    J Neuroimmunol; 1999 Jul 01; 98(1):49-56. PubMed ID: 10426362
    [Abstract] [Full Text] [Related]

  • 7. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H.
    Brain; 2010 Oct 01; 133(10):2983-98. PubMed ID: 20855416
    [Abstract] [Full Text] [Related]

  • 8. Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
    Levy H, Assaf Y, Frenkel D.
    Exp Neurol; 2010 Nov 01; 226(1):148-58. PubMed ID: 20736006
    [Abstract] [Full Text] [Related]

  • 9. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL.
    Radiology; 2000 Mar 01; 214(3):665-70. PubMed ID: 10715027
    [Abstract] [Full Text] [Related]

  • 10. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J, Zetterberg H, Fransson M, Loskog AS, Raininko R, Fagius J.
    Acta Neurol Scand; 2014 Aug 01; 130(2):81-9. PubMed ID: 24571714
    [Abstract] [Full Text] [Related]

  • 11. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J, Börnsen L, Khademi M, Olsson T, Jensen PE, Sørensen PS, Sellebjerg F.
    Mult Scler; 2013 Jun 01; 19(7):877-84. PubMed ID: 23178691
    [Abstract] [Full Text] [Related]

  • 12. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V, Suri S, Bakshi R.
    Radiology; 2007 Sep 01; 244(3):823-31. PubMed ID: 17690319
    [Abstract] [Full Text] [Related]

  • 13. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y, Nomura T, Bochimoto H, Murakami K, Tanaka T, Watanabe T, Yoshida S.
    Neurochem Int; 2015 Feb 01; 81():16-27. PubMed ID: 25595039
    [Abstract] [Full Text] [Related]

  • 14. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J.
    Arch Neurol; 2012 Jun 01; 69(6):739-45. PubMed ID: 22351849
    [Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H.
    Am J Pathol; 2000 Jul 01; 157(1):267-76. PubMed ID: 10880396
    [Abstract] [Full Text] [Related]

  • 16. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 01; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 17. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 18. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M, Liu R, Guo L, Li C, Tan G.
    APMIS; 2008 Nov 29; 116(11):972-84. PubMed ID: 19132994
    [Abstract] [Full Text] [Related]

  • 19. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb 29; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 20. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 29; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.